Fresh2 Group Limited (FRES) Short-Term Debt to Capital

Fresh2 Group Ltd - graphic logo of issuer FRES

Fresh2 Group Limited (FRES) is implementing environmental standards in B2B logistics to reduce its carbon footprint and optimize cloud services. The business relies on the continuity of food supply chains and current safety regulations. The verified price history on the GURU.Markets chart reflects a value of 0.00, while the strategic vector is shifting toward the development of software for food marketplaces.

FRES - fresh2.co Short-Term Debt to Capital over the range 02/21/2024 - 01/04/2025

Analytical breakdowns for Fresh2 (FRES)

- price and consensus price forecast:
Stock Price Fresh2 Group Limited|FRES - Average Forecast Price
- market capitalization data:
Market Capitalization Fresh2 Group Ltd|FRES - Business Value
- book capitalization data:
Book Value per Share Fresh2 Group|FRES - Book Capitalization|Market Value to Book Value Ratio fresh2.co|FRES - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Fresh2 Group Limited|FRES - Long-Term Debt to Capital|Short-Term Debt to Equity Fresh2 Group Limited|FRES - Company Debts|Debt to Book Value Fresh2 Group Ltd|FRES - Long-Term Debt|Company Short-Term Debt Fresh2 Group
Fundamental company analysis:Fresh2 Group (FRES)
Brand item of Fresh2 Group Limited

By scaling AI algorithms to automate B2B procurement in China, Fresh2 Group Limited is optimizing its operating cycle; consequently, the current level of short-term capital load, reflecting the proportion of net assets covered by liabilities under one year, serves as a liquidity indicator, where an increase in the metric signals refinancing risk, while its decrease confirms the resilience of the financial architecture during the deployment of technological infrastructure.

Competing companies

Agilent Tech - Short-Term Debt to Capital|Current Liabilities to Capital Quest Corp (DGX)|ILMN - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio exactsciences.com EXAS|Revvity - Short-Term Debt to Capital|BIO: Short-Term Debt to Capital|Short-Term Debt to Equity Anbio Tech|Nordion (SHC) - Short-Term Debt to Capital Ratio|QDEL (QuidelOrtho) - Short-Term Debt to Capital|Short-Term Debt to Capital OPK|Short-Term Debt to Equity CareDx Health (CDNA)|Short-Term Debt to Equity Maravai LifeSciences Holdings MRVI|FLGT: Short-Term Debt to Equity Ratio|Standard BioTools Corp - Current Liabilities to Capital|Short-Term Debt to Equity CTKB (Cytek Biosciences, Inc.)|OSUR - Short-Term Debt to Capital Coefficient|exagen.com - Short-Term Debt to Capital|MDXH (MDxHealth S.A.) - Short-Term Debt to Capital Coefficient|LUCD: Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Prenetics Global Ltd|IMDX - Short-Term Debt to Capital|Current Liabilities to Equity TRIB (trinitybiotech.com)|Short-Term Debt to Equity ProPhase Labs|Ratio of Short-Term Indebtedness to Capital Ainos Inc AIMD|CODX (Co-Diagnostics Corp) - Short-Term Debt to Capital|HSCS: Current Liabilities to Capital|Biomerica, Inc. - Short-Term Debt to Equity|Cardio Diagnostics Holdings (CDIO) - Short-Term Debt to Capital Coefficient|VRAX - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital BJDX|Short-Term Debt to Equity AWH (Vermillion)|AXDX (Accelerate Diagnostics Inc) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CNTG (Centogene N.V.)|Short-Term Debt to Capital Enzo Biochem Inc.|GENE - Short-Term Indebtedness to Equity|Short-Term Debt to Equity ME (23andMe Holding Co)|Psychemedics Corp (PMD) - Ratio of Short-Term Indebtedness to Capital